The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksVersarien Regulatory News (VRS)

Share Price Information for Versarien (VRS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.105
Bid: 0.10
Ask: 0.105
Change: -0.002 (-1.91%)
Spread: 0.005 (5.00%)
Open: 0.1005
High: 0.105
Low: 0.1005
Prev. Close: 0.1045
VRS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Exercise of Options

7 Dec 2017 07:00

RNS Number : 6262Y
Versarien PLC
07 December 2017
 

7 December 2017

Versarien plc

("Versarien" or the "Company")

Exercise of Options

Director/PDMR Shareholding

Versarien plc (AIM: VRS), the advanced materials engineering group, announces it has issued 910,900 ordinary shares of 1 pence each in the Company ("Ordinary Shares") following the exercise by directors and an employee of the Company under the Company's share option schemes.

Named person

No. options exercised

Exercise price per share

Neill Ricketts

250,000

12.25p

Chris Leigh

528,720

15.50p

Employee (non-PDMR)

132,180

12.25p

Total

910,900

 

 

Application has been made for the new Ordinary Shares to be admitted to trading on AIM, which is expected to take place on 11 December 2017. The new Ordinary Shares will rank, pari passu, with the existing Ordinary Shares in issue.

The Company was also notified that Christopher Leigh, Chief Financial Officer has sold 528,720 Ordinary Shares at an average price of 73.81 pence per Ordinary Share.

Following the transactions outlined above:

Mr Ricketts' interest in the share capital of the Company has increased to a total of 15,625,000 Ordinary Shares representing 10.53 per cent. of the Company's issued share capital enlarged pursuant to the exercise of options. Mr Ricketts is further interested in 278,720 options exercisable at 12.25 pence per share together with 2,626,614 options exercisable at 15 pence per share and 1,050,761 options exercisable at 29 pence per share; and

Mr Leigh's interest in the share capital of the Company has remained at a total of 315,000 Ordinary Shares representing 0.21 per cent. of the Company's issued share capital enlarged pursuant to the exercise of options. Mr Leigh is further interested in 2,626,614 options exercisable at 15 pence per share and 1,050,761 options exercisable at 29 pence per share.

Total Voting Rights

Following the issue of the new Ordinary Shares, the Company will have 148,386,309 ordinary shares of 1 pence each in issue. No Ordinary Shares are held in treasury. The figure of 148,386,309 may be used by the Company's shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure Guidance and Transparency Rules.

 

Enquiries:

Versarien 01242 269 122

Neill Ricketts, CEO

Chris Leigh, CFO

WH Ireland (Nominated Advisor) 0117 945 3470

Mike Coe / Ed Allsopp

IFC Advisory (Financial PR and IR) 0203 053 8671

Tim Metcalfe

Graham Herring

Heather Armstrong

 

The information below, set out in accordance with the requirements of the EU Market Abuse Regulation, provides further detail.

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Neill Ricketts

2

Reason for the notification

a)

Position/status

Chief Executive Officer

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Versarien plc

b)

LEI

213800D6NZED7V8W2Z34

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1p each

 

GB00B8YZTJ80

b)

Nature of the transaction

Exercise of options

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

12.25p

250,000

 

d)

Aggregated information

- Aggregated volume

- Price

 

250,000

£30,625

e)

Date of the transaction

5 December 2017

f)

Place of the transaction

London Stock Exchange, AIM

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Christopher Leigh

2

Reason for the notification

a)

Position/status

Chief Financial Officer

b)

Initial notification/ Amendment

Initial Notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Versarien plc

b)

LEI

213800D6NZED7V8W2Z34

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 1p each

 

GB00B8YZTJ80

b)

Nature of the transaction

Exercise and sale of options

c)

Price(s) and volume(s)

Exercise:

Price(s)

Volume(s)

15.50p

528,720

 

Sale:

Price(s)

Volume(s)

74.00p

73.64p

250,000

278,720

 

d)

Aggregated information

- Aggregated volume

- Price

 

- Aggregated volume

- Price

 Exercise:

528,720

£81,952

Sale:

528,720

£390,249

e)

Date of the transaction

5 December 2017

f)

Place of the transaction

London Stock Exchange, AIM

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHOKADPCBDDQBK
Date   Source Headline
12th Feb 20204:35 pmRNSPrice Monitoring Extension
11th Feb 20204:40 pmRNSSecond Price Monitoring Extn
11th Feb 20204:36 pmRNSPrice Monitoring Extension
11th Feb 20202:05 pmRNSSecond Price Monitoring Extn
11th Feb 20202:00 pmRNSPrice Monitoring Extension
11th Feb 202011:05 amRNSSecond Price Monitoring Extn
11th Feb 202011:00 amRNSPrice Monitoring Extension
10th Feb 20207:00 amRNSResponse to share price movement
21st Jan 20207:00 amRNSUS Update
18th Dec 20197:00 amRNSAirbus Graphene Flagship Project
12th Dec 20197:00 amRNSInterim Results
27th Nov 20197:00 amRNSNotice of Results
27th Nov 20197:00 amRNSTextile Commercial Partnership Agreement
1st Nov 20192:05 pmRNSSecond Price Monitoring Extn
1st Nov 20192:00 pmRNSPrice Monitoring Extension
9th Oct 20197:00 amRNSRefractory Materials Collaboration
24th Sep 20191:38 pmRNSResult of AGM
24th Sep 20197:00 amRNSAGM Statement
20th Sep 201911:47 amRNSSecond Price Monitoring Extn
20th Sep 201911:46 amRNSPrice Monitoring Extension
19th Sep 20192:05 pmRNSSecond Price Monitoring Extn
19th Sep 20192:00 pmRNSPrice Monitoring Extension
22nd Aug 20199:35 amRNSAppointment of Joint Broker
21st Aug 20191:35 pmRNSNotice of AGM and Posting of Annual Report
9th Aug 20197:54 amRNSChina Update and Clarification
6th Aug 20197:00 amRNSAnnual General Meeting
26th Jul 20197:00 amRNSLOI with Global Apparel Manufacturer
24th Jul 20197:00 amRNSTransport Infrastructure Technology Preview Event
17th Jul 20197:00 amRNSPreliminary Results
16th Jul 20197:00 amRNSInvestor Event
15th Jul 20198:00 amRNSReceipt of Graphene REACH Registration
11th Jul 201910:30 amRNSNotice of Results
8th Jul 20197:00 amRNSJapanese Graphene Order
1st Jul 20197:00 amRNSAppointment of Director
28th Jun 20197:00 amRNSUS Graphene Order
27th Jun 20192:33 pmRNSAppointment of New Head of US Operations
19th Jun 20192:16 pmRNSResponse to Commentary Regarding US Employee
29th May 20193:00 pmRNSCollaboration Agreement with BP Polymers
9th May 20197:00 amRNSUSA Update
15th Apr 20196:03 pmRNSDirector/PDMR Shareholding
15th Apr 20197:00 amRNSTerm Sheet with Beijing Institute of Graphene Tech
4th Apr 20198:29 amRNSUS Appointment Update
1st Apr 20197:00 amRNSCompletion of Verified Graphene Producer Programme
29th Mar 20197:00 amRNSExtension of DIT Secondment
21st Mar 20197:00 amRNSUSA Update
14th Mar 20197:00 amRNSLOI with Tunghsu Optoelectronic
7th Mar 201911:42 amRNSFurther Chinese Aerospace Collaboration
5th Mar 20199:00 amRNSPrice Monitoring Extension
1st Mar 20192:05 pmRNSSecond Price Monitoring Extn
1st Mar 20192:00 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.